Vaxart Inc (VXRT)
0.7839
-0.05
(-6.23%)
USD |
NASDAQ |
Apr 19, 13:45
Vaxart Cash and Short Term Investments (Quarterly): 39.71M for Dec. 31, 2023
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 39.71M |
| September 30, 2023 | 52.25M |
| June 30, 2023 | 67.90M |
| March 31, 2023 | 71.81M |
| December 31, 2022 | 95.72M |
| September 30, 2022 | 114.77M |
| June 30, 2022 | 129.55M |
| March 31, 2022 | 147.66M |
| December 31, 2021 | 166.49M |
| September 30, 2021 | 187.67M |
| June 30, 2021 | 184.58M |
| March 31, 2021 | 170.70M |
| December 31, 2020 | 126.87M |
| September 30, 2020 | 133.44M |
| June 30, 2020 | 44.39M |
| March 31, 2020 | 29.86M |
| December 31, 2019 | 13.53M |
| September 30, 2019 | 19.56M |
| June 30, 2019 | 16.26M |
| March 31, 2019 | 8.374M |
| December 31, 2018 | 11.46M |
| September 30, 2018 | 17.92M |
| June 30, 2018 | 23.92M |
| March 31, 2018 | 17.50M |
| December 31, 2017 | 29.40M |
| Date | Value |
|---|---|
| September 30, 2017 | 34.10M |
| June 30, 2017 | 38.60M |
| March 31, 2017 | 37.60M |
| December 31, 2016 | 49.20M |
| September 30, 2016 | 58.30M |
| June 30, 2016 | 69.00M |
| March 31, 2016 | 49.00M |
| December 31, 2015 | 52.00M |
| September 30, 2015 | 57.20M |
| June 30, 2015 | 57.60M |
| March 31, 2015 | 73.50M |
| December 31, 2014 | 70.80M |
| September 30, 2014 | 58.80M |
| June 30, 2014 | 81.70M |
| March 31, 2014 | 80.10M |
| December 31, 2013 | 51.40M |
| September 30, 2013 | 60.80M |
| June 30, 2013 | 66.80M |
| March 31, 2013 | 70.26M |
| December 31, 2012 | 74.11M |
| September 30, 2012 | 66.32M |
| June 30, 2012 | 92.65M |
| March 31, 2012 | 94.88M |
| December 31, 2011 | 96.39M |
| September 30, 2011 | 102.01M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
13.53M
Minimum
Dec 2019
187.67M
Maximum
Sep 2021
95.41M
Average
95.72M
Median
Dec 2022
Cash and Short Term Investments (Quarterly) Benchmarks
| aTyr Pharma Inc | 98.17M |
| Allogene Therapeutics Inc | 448.70M |
| AIM ImmunoTech Inc | 13.07M |
| Protalix BioTherapeutics Inc | 44.56M |
| Armata Pharmaceuticals Inc | 13.52M |